More on ABSI

- Summary
- Chart
- Profile
- Historical

Data

- Earnings (+5.0% Growth)
- Ratings (8.1 Score)

Upcoming Events

- Earnings (11/12/26)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Absci Corporation (NQ:ABSI)
Delayed: 8.25 -0.63 (7.09%)
Prev. Close $8.88  
Open$8.93 
52 Wk High$ 
52 Wk Low$ 
Day High$8.95 
Day Low$8.12 
P/E N/A  
EPS$ 
Volume3,550,241 

Friends, Peers and Foes (?): HYFT, ABCL, CERT, RXRX, SDGR (more...)

Oct 16, 2026 09:11 AM Absci Corp. (ABSI) PT Raised to $20 at KeyBanc
Oct 14, 2026 07:16 PM Form 4 Absci Corp For: Oct 12 Filed by: McClain Sean
Oct 14, 2026 07:16 PM Form 4 Absci Corp For: Oct 12 Filed by: Bedrick Todd
Oct 14, 2026 07:15 PM Form 4 Absci Corp For: Oct 12 Filed by: Jonasson Zachariah
Oct 14, 2026 09:45 AM AI-Designed Biologics Are Moving From the Screen to the Bench, and Developers Are Hiring for the Next Test
Oct 13, 2026 08:00 AM Absci to Report Business Updates and Third Quarter 2026 Financial and Operating Results on November 12, 2026
Sep 28, 2026 01:33 AM Guggenheim Reiterates Buy Rating on Absci Corp. (ABSI)
Sep 24, 2026 08:00 AM Absci plans Phase 2 trial of ABS-201 for endometriosis in mid-2027
Sep 24, 2026 08:00 AM Absci Announces Preliminary Details for Phase 2 STORYLINE™ Trial of AI-Designed Antibody ABS-201™ for Endometriosis
Sep 1, 2026 08:00 AM Absci to Participate in Upcoming Investor Conferences
View All Articles

Entities mentioned with ABSI

View All Entities